GENBIOMA

At Genbioma, we are revolutionizing metabolic health with microbiome-based solutions designed for the nutraceutical and food industries. We are pioneers in developing pA1c®HI, the first clinically validated postbiotic for glucose control—a natural, safe, and extremely stable ingredient that is transforming the market.

pA1c®HI offers a unique combination of proven efficacy, complete thermal stability (UHT, pasteurization), and versatile formulation, making it the ideal choice for advanced supplements and functional foods. Its clinical evidence in prediabetes, type 2 diabetes, and obesity positions it as a standout ingredient for brands seeking to innovate with high-impact solutions for consumers.

Thanks to our proprietary development platform and an international network of industrial partners, we accelerate the market launch of disruptive functional ingredients. At Genbioma, we empower brands to lead the new generation of products for cardiometabolic wellness.